PCVX
PCVX
NASDAQ · Biotechnology

Vaxcyte Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$58.92
+0.79 (+1.36%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +13.8% upside
Low Target $56.09
Average Target $67.08
High Target $108.72
Current Price $58.92
Current
$58.92
Target
$67.08
$56.09 $67.08 avg $108.72
Scenario Analysis
Bear Case
$56.09
-4.8%
Low target
Base Case
$67.08
+13.8%
Avg target
Bull Case
$108.72
+84.5%
High target
Risk/Reward
17.6x
Highly favorable
Price in Context
52-Week High
$65.00
-9.4% from high
52-Week Low
$30.81
+91.2% from low
50-Day SMA
$49.46
+19.1% vs SMA
200-Day SMA
$39.88
+47.7% vs SMA
RSI (14)
62.6
Neutral
Target vs 52W High
$67.08
+3.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -3.0%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.4%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -15.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%